Abiopharma

🔍 Romaine Mark (Executive)

Company: GLOBAL PARTNERS LP (GLP)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Sold 2,065 shares of Common Units representing limited partner interests at $44.8 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 139,109.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Common Units representing limited partner interests in the Issuer ("Common Units") were sold at a weighted average price. These Common Units were sold in multiple transactions at prices from $44.56 to $45.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Units sold at each separate price within the range set forth in this footnote (1) to this Form 4.